Phase I Trial of Radical Thoracic Radiation, Weekly CPT-11 (Irinotecan) and Cisplatin in Locally Advanced Non-Small Cell Lung Carcinoma.
Phase of Trial: Phase I
Latest Information Update: 30 Aug 2013
At a glance
- Drugs Irinotecan (Primary) ; Cisplatin
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 16 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Feb 2010 Planned end date (Sep 2006) added as reported by ClinicalTrials.gov.
- 13 Sep 2005 New trial record.